Insilico Medicine Highlights AI-Driven Innovations at BIO 2026 International Convention
Cambridge, MA — May 29, 2025 — Insilico Medicine, a trailblazer in AI-driven drug discovery, is gearing up to spotlight ...
Tag: generative artificial intelligence in pharmaceuticals
Insilico Medicine and CMS Forge Multiple Collaborations to Accelerate AI-Driven R&D in CNS and Autoimmune Disorders
In a groundbreaking announcement set to redefine the future of pharmaceutical innovation, Insilico Medicine and China Medical System Holdings Limited ...
Insilico Medicine Publishes Phase IIa Results in Nature Medicine on Rentosertib, Novel AI-Designed TNIK Inhibitor for Idiopathic Pulmonary Fibrosis
In a groundbreaking advancement in pharmaceutical science, Insilico Medicine has unveiled the first proof-of-concept clinical validation of a drug discovered ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!